Sensodetect participates in Shareholder associations event in Gothenburg
A presentation of SensoDetect with an emphasis on the new approach and the progress so far conducted by CEO Johan Olson at Aktiedagen on 27 November in Gothenburg. Shareholders Association (Aktiespararna) is hosting the event, which is one of the year's biggest stock events. Starting at 9.20 am a presentation is also available via webcast for those who can't attend (20 minutes presentation) and then followed by q & a on 10 minutes which also will be webcasted.
CEO Johan Olson will present the company, the new strategy and the overall progress so far. Interested parties shall be given opportunity to ask questions during the presentation or in connection with the arrangement. Shareholders association stock day (Aktiespararnas Aktiedag) in Gothenburg is one of the year's biggest events with several hundred expected visitors to the seminars. In addition to that, serveral thousnads will take part in the event via the web.
Sensodetect BERA ® is a unique product that cost effectively can capture brainstem response of audio stimuli which can be used by Psychiatry as a complement to other observations at the screening of patients. For example, it is scientifically well highlighted that there is a clear link between ADHD and the part of the brain called the thalamus, this has been demonstrated, inter alia, with functional MRI. SensoDetects brainstem audiometer is a tool for detecting an abnormality in such as the thalamus. The user receives an objective metric which, like an elevated blood pressure, can be used as a supplement to support or reject a hypothesis in the diagnosis.
"- We are very pleased that we received the invitation to take part in this event and present SensoDetect, not least, to provide a picture of our new strategy and the process so far. We see this as a good opportunity to highlight our company and our view of the market going forward. I will use the opportunity to present the Board's and my image/vision on how we build a successful company.", says CEO Johan Olson
VD, SensoDetect Aktiebolag (publ)
Phone: +46 705 424600
SensoDetect highlights through patented equipment brain stem responses to audio stimuli in order to provide health care clear anomalies and patterns for use primarily within psychiatry. The goal is to increase efficiency in Psychiatry and thus the benefits for health care, society, patients and relatives.
Improve the lives of people with mental illness
Making ABR profiling tests with SensoDetect technology an integral part of setting diagnosis for mental illness
Our Value Proposition:
SensoDetect provides a complete audiogram for the brainstem, helping health care professional to set psychiatric diagnoses objectively and
cost effectively. This unique offering improves patients’ quality of life and reduces the economic impact on the health care system and society